Understanding the Social Impact of Digital Platforms: A Student Analysis Based on Recent Research

Abstract

Background:
Type 2 diabetes mellitus (T2DM) is a major public health problem in India, with a rising prevalence and a high
burden of microvascular and macrovascular complications. Poor medication adherence is one of the key reasons
for inadequate glycaemic control and long-term complications, especially in resource-limited settings. Clinical
pharmacists can play a crucial role in counselling, regimen simplification, and identifying drug-related
problems.
Objectives:
To assess the effect of a structured clinical pharmacist-led intervention on (1) medication adherence and (2)
glycaemic control (HbA1c) among patients with T2DM attending a tertiary care hospital.
Methods:
This prospective, interventional, single-centre study will be conducted in the Department of
Medicine/Endocrinology of a tertiary care teaching hospital in India. Adult patients (≥ 18 years) with T2DM for
≥ 1 year, on anti-diabetic medication for ≥ 6 months, and HbA1c ≥ 7% will be enrolled. Baseline data will
include demographics, clinical profile, current therapy, and medication adherence assessed using the 8-item
Morisky Medication Adherence Scale (MMAS-8). All participants will receive a structured clinical pharmacistled intervention comprising individual counselling, a patient information leaflet, a personalised dose-timing
chart, and telephonic reinforcement. Primary outcomes will be change in adherence score and change in HbA1c
at 3 and 6 months. Secondary outcomes will include changes in fasting and post-prandial blood glucose, blood
pressure and lipid parameters, self-reported hypoglycaemia, and the number and type of drug-related problems
identified and resolved.